Drugs / ppDC
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT06342908 | Jun 2024 → Mar 2027 expected | diffuse glioma, H3 G34 mutant | Jonsson Comprehensive Cancer Center | Active not recruiting | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ppDC | “Patients then receive ppDC intradermally (ID) with poly ICLC intramuscularly (IM)” NCT06342908 ↗ |